Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLADRIBINE for Rosai-dorfman syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where CLADRIBINE was used for Rosai-dorfman syndrome.

Most Reported Side Effects for CLADRIBINE

Side Effect Reports % Deaths Hosp.
Fatigue 696 9.3% 4 77
Headache 579 7.7% 2 53
Lymphocyte count decreased 448 6.0% 3 125
Multiple sclerosis relapse 404 5.4% 2 151
Nausea 354 4.7% 5 53
Pneumonia 318 4.2% 35 121
White blood cell count decreased 311 4.1% 3 64
Urinary tract infection 242 3.2% 6 132
Pyrexia 207 2.8% 20 115
Multiple sclerosis 206 2.7% 4 60
Off label use 197 2.6% 34 48
Asthenia 195 2.6% 6 68
Drug ineffective 189 2.5% 32 38
Lymphopenia 188 2.5% 2 52
Covid-19 179 2.4% 15 72

Other Indications for CLADRIBINE

Multiple sclerosis (5,360) Relapsing-remitting multiple sclerosis (581) Hairy cell leukaemia (331) Acute myeloid leukaemia (281) Product used for unknown indication (162) Relapsing multiple sclerosis (123) Langerhans' cell histiocytosis (116) Chronic lymphocytic leukaemia (38) Secondary progressive multiple sclerosis (32) Erdheim-chester disease (17)

Other Drugs Used for Rosai-dorfman syndrome

RITUXIMAB (36) COBIMETINIB (32) METHOTREXATE (28) PREDNISONE (22) LENALIDOMIDE (20) MERCAPTOPURINE (17) PREDNISOLONE (17) ETOPOSIDE (13) IMATINIB (13) CLOFARABINE (9)

Related Pages

CLADRIBINE Full Profile All Rosai-dorfman syndrome Drugs CLADRIBINE Demographics CLADRIBINE Timeline